<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000641153">
  <TermName>TRAIL-R2</TermName>
  <TermPronunciation>(trayl …)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A protein on the surface of certain cells that binds another protein called TRAIL, which may kill some cancer cells. An increase in the amount or activity of TRAIL-R2 on cancer cells may kill more cells. Also called death receptor 5, DR5, TRAIL receptor 2, and tumor necrosis factor receptor superfamily member 10B.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000733123" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;TRAIL-R2&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000733122" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;TRAIL-R2&quot;" language="es" id="_4"/>
  <SpanishTermName>TRAIL-R2</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Proteína de la superficie de ciertas células que se une a otra proteína que se llama TRAIL, que puede destruir células cancerosas. Un aumento de la cantidad o actividad del TRAIL-R2 en las células cancerosas puede destruir más células. También se llama DR5, miembro 10B de la superfamilia de receptores del factor de necrosis tumoral, receptor de muerte 5 y receptor TRAIL 2.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-05-08</DateFirstPublished>
</GlossaryTerm>
